Scientific and Medical Equipment House Company (4014.SR)
SAR 41.3
(0.12%)
SAR 41.3
(0.12%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 345.88 Million SAR | 127.56% |
| 2022 | 151.99 Million SAR | -31.2% |
| 2021 | 220.92 Million SAR | 175.85% |
| 2020 | -291.27 Million SAR | 6.51% |
| 2019 | -311.54 Million SAR | -7.15% |
| 2018 | -290.74 Million SAR | -380.98% |
| 2017 | 103.47 Million SAR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 227.97 Million SAR | -7.16% |
| 2024 Q1 | 245.54 Million SAR | -29.01% |
| 2023 Q4 | 345.88 Million SAR | 6.68% |
| 2023 FY | 345.88 Million SAR | 127.56% |
| 2023 Q3 | 324.23 Million SAR | 35.01% |
| 2023 Q2 | 240.15 Million SAR | 21.04% |
| 2023 Q1 | 198.41 Million SAR | 30.54% |
| 2022 Q3 | 228.59 Million SAR | -23.26% |
| 2022 Q2 | 297.88 Million SAR | 6.71% |
| 2022 FY | 151.99 Million SAR | -31.2% |
| 2022 Q1 | 279.14 Million SAR | 26.36% |
| 2022 Q4 | 151.99 Million SAR | -33.51% |
| 2021 Q2 | 180.86 Million SAR | 104.05% |
| 2021 Q1 | 88.63 Million SAR | -11.29% |
| 2021 FY | 220.92 Million SAR | 175.85% |
| 2021 Q4 | 220.92 Million SAR | 0.0% |
| 2020 FY | -291.27 Million SAR | 6.51% |
| 2020 Q1 | 74.25 Million SAR | 0.0% |
| 2020 Q4 | 99.91 Million SAR | 0.0% |
| 2020 Q3 | 99.91 Million SAR | 0.0% |
| 2019 FY | -311.54 Million SAR | -7.15% |
| 2018 FY | -290.74 Million SAR | -380.98% |
| 2017 FY | 103.47 Million SAR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|